Swedencare AB (publ) (STO:SECARE)

Sweden flag Sweden · Delayed Price · Currency is SEK
27.05
+0.45 (1.69%)
Jun 10, 2026, 5:29 PM CET
Market Cap4.32B -34.1%
Revenue (ttm)2.70B +4.6%
Net Income49.30M -46.8%
EPS0.31 -47.1%
Shares Out 159.84M
PE Ratio87.70
Forward PE22.93
Dividend0.28 (1.05%)
Ex-Dividend DateApr 24, 2026
Volume174,021
Open26.60
Previous Close26.60
Day's Range26.05 - 27.20
52-Week Range22.40 - 49.25
Beta0.56
AnalystsBuy
Price Target42.00 (+55.27%)
Earnings DateJul 22, 2026

About Swedencare AB

Swedencare AB (publ), together with its subsidiaries, develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally. The company offers animal nutritional supplements, treats, and grooming products for dogs under the Healthy Breeds name; pet supplements and topical products for various therapeutic areas, such as orthopedics, behavior, dermatology, odontostomatology, algology, gastroenterology, urology, nephrology, and ophthalmology under the Innovet name; and suppo... [Read more]

Founded 1993
Employees 591
Stock Exchange Nasdaq Stockholm
Ticker Symbol SECARE
Full Company Profile

Financial Performance

In 2025, Swedencare AB's revenue was 2.69 billion, an increase of 6.13% compared to the previous year's 2.54 billion. Earnings were 55.50 million, a decrease of -43.88%.

Financial Statements

Analyst Summary

According to 3 analysts, the average rating for SECARE stock is "Buy." The 12-month stock price target is kr 42.00, which is an increase of 55.27% from the latest price.

Price Target
kr 42.00
(55.27% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Swedencare AB Earnings Call Transcript: Q1 2026

Double-digit organic growth and record gross margin were achieved, driven by strong European and online sales, while North America stabilized and production segments rebounded. Major new contracts, product launches, and operational efficiencies support a positive outlook for 2026.

6 weeks ago - Transcripts

Swedencare AB Quarterly report: Q1 2026

Swedencare AB has published its Q1 2026 quarterly earnings report on April 23, 2026.

6 weeks ago - Filings

Swedencare AB Slides: Q1 2026

Swedencare AB has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 23, 2026.

6 weeks ago - Filings

Swedencare AB Transcript: Pre-close call

Stable demand and improved operational efficiency are driving higher margins and profitability, with strong growth in North America, Europe, and contract manufacturing. Walmart and Amazon channels show positive trends, and cost headwinds remain limited.

2 months ago - Transcripts

Swedencare AB Slides: Pre-close call

Swedencare AB has posted slides in relation to its latest quarterly earnings report, which was published on March 20, 2026.

2 months ago - Filings

Swedencare AB Earnings Call Transcript: Q4 2025

Q4 2025 saw strong organic growth but disappointing profitability due to one-off costs, marketing overspend, and inventory write-offs. Improved cost controls, new product launches, and a focus on pharma and online channels are expected to drive margin recovery and growth in 2026.

4 months ago - Transcripts

Swedencare AB Annual report: Q4 2025

Swedencare AB has published its Q4 2025 annual report on February 12, 2026.

4 months ago - Filings

Swedencare AB Quarterly report: Q4 2025

Swedencare AB has published its Q4 2025 quarterly earnings report on February 12, 2026.

4 months ago - Filings

Swedencare AB Slides: Q4 2025

Swedencare AB has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 12, 2026.

4 months ago - Filings

SwedenCare downgraded to Hold from Buy at Nordea

Nordea downgraded SwedenCare (SWDCF) to Hold from Buy.

4 months ago - TheFly

Swedencare AB Slides: SEB Nordic Seminar presentation

Swedencare AB has posted slides in relation to its latest quarterly earnings report, which was published on January 7, 2026.

5 months ago - Filings

Swedencare AB Earnings Call Transcript: Q3 2025

Record Q3 revenue and EBITDA were achieved, driven by strong growth in North America and Europe, major US retail expansion, and robust online sales. Outlook remains positive with double-digit growth and margin improvement expected, despite some margin pressure from marketing investments.

8 months ago - Transcripts

Swedencare AB Quarterly report: Q3 2025

Swedencare AB has published its Q3 2025 quarterly earnings report on October 22, 2025.

8 months ago - Filings

Swedencare AB Slides: Q3 2025

Swedencare AB has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on October 22, 2025.

8 months ago - Filings

Swedencare AB Earnings Call Transcript: Q2 2025

Q2 2025 saw 3% sales growth and 7% organic growth, with margins impacted by the Amazon transition and delayed Walmart order. H2 is expected to deliver double-digit growth and improved profitability, driven by new launches, online momentum, and operational efficiencies.

11 months ago - Transcripts

Swedencare AB Quarterly report: Q2 2025

Swedencare AB has published its Q2 2025 quarterly earnings report on July 23, 2025.

11 months ago - Filings

Swedencare AB Slides: Q2 2025

Swedencare AB has posted slides in relation to its Q2 2025 quarterly earnings report, which was published on July 23, 2025.

11 months ago - Filings